More U.S. women know how breast density impacts cancer risk
(Reuters Health) – A growing number of U.S. women understand that breast density can impact cancer risk, but a new study suggests this isn’t prompting more patients to discuss the…
Supplements touting brain benefits may contain unauthorized ingredient
(Reuters Health) – Many supplements marketed for brain health may contain piracetam, an ingredient not proven effective for preventing or easing dementia or cognitive impairment and not approved for sale…
ImmuPharma licenses lupus drug Lupuzor to Avion in the United States
LONDON (Reuters) – British pharmaceutical firm ImmuPharma said on Thursday it had signed a licensing and development agreement for Lupuzor, a first-in-class treatment for auto-immune disease Lupus, with U.S. company…
Novartis’s $90 million Swiss factory to help solve cell therapy bottleneck
ZURICH (Reuters) – Swiss drugmaker Novartis’s (NOVN.S) new $90 million cell and gene therapy factory in northern Switzerland is on track to begin commercial production of its cell therapy Kymriah…
AstraZeneca’s Imfinzi gets speedy FDA review for small cell lung cancer
FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange, U.S., April 8, 2019. REUTERS/Brendan McDermid (Reuters)…
Teva partners with Israeli institutes for early-stage drug research
FILE PHOTO: The logo of Teva Pharmaceutical Industries is seen during a news conference by its CEO, Kare Schultz, to discuss the company’s 2019 outlooks in Tel Aviv, Israel February…
Adamis shares slump as FDA declines to approve opioid overdose treatment
(Reuters) – Adamis Pharmaceuticals Corp (ADMP.O) said on Monday the U.S. Food and Drug Administration declined to approve its opioid overdose treatment, Zimhi, sending its shares plunging 56%. In a…
CymaBay Therapeutics scraps two studies of liver drug; shares plunge
(Reuters) – CymaBay Therapeutics Inc said on Monday it was scrapping two mid-stage trials of its liver disease drug, after biopsies found a type of liver damage in some patients,…
New Roche flu drug can drive resistance in influenza viruses: researchers
CHICAGO (Reuters) – Roche’s influenza treatment Xofluza, a one-dose pill that can clear flu symptoms within days, may cause a mutation of the virus that leads to drug resistance, researchers…
FDA approves Global Blood Therapeutics sickle cell disease drug
(Reuters) – The U.S. Food and Drug Administration said on Monday it approved a drug from Global Blood Therapeutics Inc to treat sickle cell disease in adults and children 12…